Arcus Biosciences (RCUS) Stock Chart & Stock Price History $9.53 +0.20 (+2.14%) As of 03:05 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Arcus Biosciences Stock Price Performance The Arcus Biosciences (RCUS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 36.93%, with a year-to-date return of -36.00%. In the past month, the stock has increased 3.03%, reflecting recent market activity. As of the latest close, Arcus Biosciences traded at $9.35 with a market cap of $990.07 million and volume of 545,958 shares. Five years ago, the stock traded at $22.66, representing a 57.94% decrease over that period. At the time, it had a market cap of $1.05 billion and a volume of 562,500 shares. Receive RCUS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arcus Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.36%1 Month Performance+3.03%3 Month Performance+24.25%Year-To-Date Performance-36.00%1 Year Performance-36.93%5 Year Performance-57.94% RCUS Stock Chart for Monday, July, 14, 2025 RCUS Chart by TradingView Arcus Biosciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$9.51$9.35-1.63%$9.48$9.25545,958 shs$990.07 million07/10/2025$9.31$9.51+2.09%$9.97$9.28688,727 shs$1.01 billion07/09/2025$8.53$9.31+9.14%$9.39$8.57818,492 shs$985.84 million07/08/2025$8.23$8.53+3.65%$8.65$8.231.43 million shs$903.24 million07/07/2025$8.47$8.23-2.78%$8.39$8.03858,707 shs$871.48 million07/04/2025$8.47$8.47$8.75$8.33297,205 shs$896.36 million07/03/2025$8.59$8.47-1.46%$8.75$8.33297,205 shs$896.36 million07/02/2025$8.35$8.59+2.87%$8.81$8.30710,232 shs$909.55 million07/01/2025$8.17$8.35+2.20%$8.61$7.921.09 million shs$884.18 million06/30/2025$7.94$8.17+2.84%$8.41$8.011.12 million shs$865.12 million Get the Latest News and Ratings for RCUS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arcus Biosciences and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$8.53$7.94-6.82%$8.64$7.913.75 million shs$841.19 million06/26/2025$8.60$8.53-0.87%$8.75$8.48637,295 shs$902.71 million06/25/2025$8.77$8.60-1.88%$8.75$8.361.28 million shs$910.65 million06/24/2025$8.65$8.77+1.39%$8.87$8.48681,000 shs$928.13 million06/23/2025$8.67$8.65-0.23%$8.75$8.38638,875 shs$915.38 million06/20/2025$8.53$8.67+1.54%$8.74$8.311.33 million shs$917.54 million06/19/2025$8.53$8.53$8.87$8.51846,882 shs$903.67 million06/18/2025$8.73$8.53-2.25%$8.87$8.51846,882 shs$903.62 million06/17/2025$9.08$8.73-3.88%$9.18$8.69861,569 shs$924.38 million06/16/2025$9.25$9.08-1.82%$9.35$8.92655,187 shs$961.65 million06/13/2025$9.37$9.25-1.28%$9.34$8.94781,402 shs$979.44 million Related Companies SpringWorks Therapeutics Stock Chart Avidity Biosciences Stock Chart ACADIA Pharmaceuticals Stock Chart Scholar Rock Stock Chart Viking Therapeutics Stock Chart Protagonist Therapeutics Stock Chart MoonLake Immunotherapeutics Stock Chart Metsera Stock Chart Kymera Therapeutics Stock Chart Immunovant Stock Chart Receive RCUS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arcus Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:RCUS) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcus Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcus Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
